Literature DB >> 23295992

Pharma fines increase, but the pain is not felt on Wall Street.

Susan Matthews.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23295992     DOI: 10.1038/nm0113-5

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.

Authors:  Meredith J Chace; Fang Zhang; Catherine A Fullerton; Haiden A Huskamp; Daniel Gilden; Stephen B Soumerai
Journal:  J Clin Psychiatry       Date:  2012-10-16       Impact factor: 4.384

  1 in total
  3 in total

1.  Unhealthy marketing of pharmaceutical products: An international public health concern.

Authors:  Shai Mulinari
Journal:  J Public Health Policy       Date:  2016-02-25       Impact factor: 2.222

2.  Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.

Authors:  Anna V Zetterqvist; Juan Merlo; Shai Mulinari
Journal:  PLoS Med       Date:  2015-02-17       Impact factor: 11.069

3.  Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.

Authors:  Andreas Vilhelmsson; Courtney Davis; Shai Mulinari
Journal:  PLoS Med       Date:  2016-01-26       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.